| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/18/2001 | WO2001077147A2 New bromodomain protein |
| 10/18/2001 | WO2001077137A1 Albumin fusion proteins |
| 10/18/2001 | WO2001076627A1 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 10/18/2001 | WO2001026608A3 Dna vaccines encoding antigen linked to a domain that binds cd40 |
| 10/18/2001 | US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries |
| 10/18/2001 | US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease |
| 10/18/2001 | US20010031474 Chimeric neuropeptide Y receptors |
| 10/18/2001 | US20010031261 Use of genetically engineered antibodies to treat multiple myeloma |
| 10/18/2001 | DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation |
| 10/18/2001 | CA2406448A1 Identification of a human gaba transporter |
| 10/18/2001 | CA2405912A1 Albumin fusion proteins |
| 10/18/2001 | CA2405800A1 Novel secreted protein |
| 10/18/2001 | CA2405730A1 Serine-threonine kinase |
| 10/18/2001 | CA2405725A1 Identification of a novel dual specificity phosphataes |
| 10/18/2001 | CA2405181A1 Human pyruvate dehydrogenese phosphatase |
| 10/18/2001 | CA2405083A1 New bromodomain protein |
| 10/18/2001 | CA2404779A1 Human lipid binding protein 1 |
| 10/18/2001 | CA2403425A1 Multivalent antibodies and uses therefor |
| 10/18/2001 | CA2403003A1 T2r taste receptors and genes encoding same |
| 10/18/2001 | CA2401836A1 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 10/17/2001 | EP1146125A1 Poxvirus with targeted infection specificity |
| 10/17/2001 | EP1145004A1 Methods for detecting changes to cellular components |
| 10/17/2001 | EP1145003A1 Method for identifying the ligands of a receptor capable of being internalized |
| 10/17/2001 | EP1144655A2 Regulated expression using conditional er retention domains |
| 10/17/2001 | EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 10/17/2001 | EP1144634A2 Novel complex-forming proteins |
| 10/17/2001 | EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 10/17/2001 | EP1144627A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 10/17/2001 | EP1144593A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 10/17/2001 | EP1144454A2 Modified peptides as therapeutic agents |
| 10/17/2001 | EP1144439A2 Hematopoietic regulatory factors and methods of use thereof |
| 10/17/2001 | EP0617706B1 Multivalent antigen-binding proteins |
| 10/17/2001 | CN1318070A Modified i(E.coli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein |
| 10/17/2001 | CN1073118C Diagnostics virus of hepatitis C |
| 10/16/2001 | US6303769 Lerk-5 dna |
| 10/16/2001 | US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies |
| 10/16/2001 | US6303341 Genetically engineered antibody for use in immunotherapy |
| 10/16/2001 | US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist |
| 10/16/2001 | US6303287 Evaluating binding activity of particles to preferential protein domains; mix binding domain and chemical particles |
| 10/16/2001 | US6303128 Method for protein expression |
| 10/16/2001 | US6303121 Method of using human receptor protein 4-1BB |
| 10/16/2001 | CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 10/11/2001 | WO2001075453A2 Methods involving induced dimerisation by cellular components |
| 10/11/2001 | WO2001075110A2 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 10/11/2001 | WO2001074855A2 Compositions and methods for dendritic cell-based immunotherapy |
| 10/11/2001 | WO2001074848A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 10/11/2001 | WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 10/11/2001 | WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 10/11/2001 | WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 10/11/2001 | US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 10/11/2001 | CA2405484A1 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 10/11/2001 | CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 10/11/2001 | CA2403998A1 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | CA2403964A1 Compositions and methods for dendritic cell-based immunotherapy |
| 10/11/2001 | CA2399934A1 Methods involving induced dimerisation by cellular components |
| 10/10/2001 | EP1141331A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 10/10/2001 | EP1141306A2 Streptococcus antigens |
| 10/10/2001 | EP1141305A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 10/10/2001 | EP1141304A2 Production of recombinant monellin using methylotrophic yeast expression system |
| 10/10/2001 | EP1141296A2 Interferon-epsilon |
| 10/10/2001 | EP1141294A1 Method of enhancing the biological activity of ligands |
| 10/10/2001 | EP1141292A1 Monocyte-derived nucleic acids and related compositions and methods |
| 10/10/2001 | EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 10/10/2001 | EP1141287A1 Pancreatic polypeptide zsig66 |
| 10/10/2001 | EP1141286A1 Cytokine receptor chain |
| 10/10/2001 | EP1141284A2 Methods and compositions for inhibiting neoplastic cell growth |
| 10/10/2001 | EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy |
| 10/10/2001 | EP1141248A2 A METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-$g(b) RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 10/10/2001 | EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 10/10/2001 | EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 10/10/2001 | EP1141007A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation |
| 10/10/2001 | EP1141003A1 Methods |
| 10/10/2001 | EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140987A1 Peptides for inhibiting hpv e6 proteins |
| 10/10/2001 | EP1140973A1 Protein-protein interactions in neurodegenerative disorders |
| 10/10/2001 | EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 10/10/2001 | EP0668909B1 Transgenic, cross-linked hemoglobin |
| 10/10/2001 | CN1317052A Proteases fused with variants of streptomyces subtilisin proteases inhibitor |
| 10/10/2001 | CN1316910A Composition and methods for regulating lymphocyte activation |
| 10/10/2001 | CN1316432A Cell death inhibitory albumen |
| 10/10/2001 | CN1316431A Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application |
| 10/09/2001 | US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 10/09/2001 | US6300099 Methods for producing secreted ligand-binding fusion proteins |
| 10/09/2001 | US6300089 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 10/09/2001 | US6299877 Used in therapy |
| 10/09/2001 | US6299876 Cytotoxic drug therapy |
| 10/09/2001 | US6299869 Human interferon-epsilon: a type I interferon |
| 10/04/2001 | WO2001073086A2 Method for genetically modifying a plant |
| 10/04/2001 | WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | WO2001073015A1 Identification of human gaba transporter |
| 10/04/2001 | WO2001073014A1 Human survivin interacting protein 1 (sip-1) |
| 10/04/2001 | WO2001072846A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | WO2001072772A2 Calcium binding regulatory subunit |
| 10/04/2001 | WO2001072769A2 Methods for purifying highly anionic proteins |
| 10/04/2001 | WO2001072768A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |